Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Dear Readers, If you’re reading this, you have likely received letters from me before, highlighting STAT’s coverage of health and medicine and appealing ...

Opinion: Only 8% of voters surveyed ranked health care as a top issue. But the results of this election will undermine ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Here are 10 influencers, entrepreneurs and lawmakers who are amplifying Robert F. Kennedy Jr.'s "Make America Healthy Again" message.

Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development timelines.

Opinion: The tiny tattoos of radiation therapy many cancer patients receive take an emotional toll — but they're increasingly unnecessary.

The president-elect campaigned on promises to shake up public health institutions, reshape federal health programs, and slash ...

The mixed results in the 10 states where abortion was on the ballot could embolden Republicans who want more restrictions.

Congress will face big health care issues next year, such as the expiration of enhanced Affordable Care Act subsidies.